An RCT Evaluating the Efficacy of Using Platelet-Rich Fibrin (PRF) with Conventional Technique of Cleft Palate Repair.

IF 1.3 4区 医学 Q2 Dentistry
Cleft Palate-Craniofacial Journal Pub Date : 2026-11-01 Epub Date: 2026-04-15 DOI:10.1177/10556656261422847
Soujanya M, Rajesh S Powar
{"title":"An RCT Evaluating the Efficacy of Using Platelet-Rich Fibrin (PRF) with Conventional Technique of Cleft Palate Repair.","authors":"Soujanya M, Rajesh S Powar","doi":"10.1177/10556656261422847","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveTo evaluate the effectiveness of platelet-rich fibrin (PRF) in the repair of cleft palate (CP), with a primary goal of reducing the occurrence of postoperative palatal fistula formation.DesignAn RCT was conducted with a 1:1 allocation ratio.SettingSingle-center study conducted in the Department of Plastic & Reconstructive Surgery at a tertiary care center.Participants100 CP repair patients enrolled based on the following inclusion criteria: Non-syndromic CPAge between 1 and 3 yearsInformed consent.InterventionsParticipants were randomized using a computer-generated sequence into 2 groups (<i>n</i> = 50 each). The intervention group received PRF, prepared by Choukroun's method from a 5 to 7 mL blood sample, and applied during surgery. The control group underwent standard CP repair without PRF. Both groups received identical pre & postoperative care.Main OutcomesPalatal-fistula formation, wound dehiscence, and postoperative bleeding were assessed.No cases of wound dehiscence or postoperative bleeding were observed in either group.Palatal fistula occurred in 3 patients (6%) in the control group (non-PRF), while no cases were observed in the PRF group.ResultsThree palatal fistula cases were observed (3%; <i>n</i> = 100), 0% in the PRF group (<i>n</i> = 50), and 6% in the non-PRF group (<i>n</i> = 50).ConclusionsWhile PRF appears to be safe, biologically promising, and cost-effective adjunct in CP repair; the study was inconclusive as the small number of fistula occurrence limited ability to statistically substantiate its efficacy in reducing palatal fistula.</p>","PeriodicalId":49220,"journal":{"name":"Cleft Palate-Craniofacial Journal","volume":" ","pages":"3690-3698"},"PeriodicalIF":1.3000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cleft Palate-Craniofacial Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10556656261422847","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0

Abstract

ObjectiveTo evaluate the effectiveness of platelet-rich fibrin (PRF) in the repair of cleft palate (CP), with a primary goal of reducing the occurrence of postoperative palatal fistula formation.DesignAn RCT was conducted with a 1:1 allocation ratio.SettingSingle-center study conducted in the Department of Plastic & Reconstructive Surgery at a tertiary care center.Participants100 CP repair patients enrolled based on the following inclusion criteria: Non-syndromic CPAge between 1 and 3 yearsInformed consent.InterventionsParticipants were randomized using a computer-generated sequence into 2 groups (n = 50 each). The intervention group received PRF, prepared by Choukroun's method from a 5 to 7 mL blood sample, and applied during surgery. The control group underwent standard CP repair without PRF. Both groups received identical pre & postoperative care.Main OutcomesPalatal-fistula formation, wound dehiscence, and postoperative bleeding were assessed.No cases of wound dehiscence or postoperative bleeding were observed in either group.Palatal fistula occurred in 3 patients (6%) in the control group (non-PRF), while no cases were observed in the PRF group.ResultsThree palatal fistula cases were observed (3%; n = 100), 0% in the PRF group (n = 50), and 6% in the non-PRF group (n = 50).ConclusionsWhile PRF appears to be safe, biologically promising, and cost-effective adjunct in CP repair; the study was inconclusive as the small number of fistula occurrence limited ability to statistically substantiate its efficacy in reducing palatal fistula.

富血小板纤维蛋白(PRF)联合传统腭裂修复技术的临床疗效评价。
目的探讨富血小板纤维蛋白(PRF)在腭裂修复中的应用效果,以降低腭裂术后腭瘘的发生率为主要目的。设计一项随机对照试验,按1:1分配比例进行。背景:在某三级护理中心整形与重建外科进行的单中心研究。参与者:100例CP修复患者根据以下纳入标准入组:1 - 3年无综合征性CPAge知情同意。干预措施使用计算机生成的序列将参与者随机分为两组(每组n = 50)。干预组患者接受5 ~ 7ml血液标本经Choukroun法制备的PRF,术中应用。对照组行标准CP修复,无PRF。两组均接受相同的术前和术后护理。主要结果:评估腭瘘形成、伤口裂开和术后出血。两组均未见创面裂开及术后出血。对照组(非PRF组)出现3例(6%)腭瘘,PRF组无一例。结果腭裂瘘3例(3%,n = 100), PRF组为0% (n = 50),非PRF组为6% (n = 50)。结论:PRF是一种安全、具有生物学前景和成本效益的CP修复辅助药物;由于瘘管发生率低,限制了统计证实其减少腭瘘疗效的能力,因此该研究尚无定论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cleft Palate-Craniofacial Journal
Cleft Palate-Craniofacial Journal DENTISTRY, ORAL SURGERY & MEDICINE-SURGERY
CiteScore
2.20
自引率
36.40%
发文量
0
审稿时长
4-8 weeks
期刊介绍: The Cleft Palate-Craniofacial Journal (CPCJ) is the premiere peer-reviewed, interdisciplinary, international journal dedicated to current research on etiology, prevention, diagnosis, and treatment in all areas pertaining to craniofacial anomalies. CPCJ reports on basic science and clinical research aimed at better elucidating the pathogenesis, pathology, and optimal methods of treatment of cleft and craniofacial anomalies. The journal strives to foster communication and cooperation among professionals from all specialties.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书